New hope for hepatitis b: experimental drug LW231 enters human trials
Disease control
Recruiting now
This study tests a new medicine called LW231 in people with chronic hepatitis B. The goal is to see if it is safe and can lower the amount of virus in the blood. Some participants will get LW231 alone, and others will get it together with standard antiviral pills. The study invol…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC